Profilo
Yasushi Sakai served as an Outside Director at SB-Kawasumi Laboratories, Inc. and later worked at Olympus Corp.
as the Chief Financial Officer from 2019 to 2020.
Precedenti posizioni note di Yasushi Sakai
| Società | Posizione | Fine |
|---|---|---|
| KAWASUMI LABORATORIES, INCORPORATED | Direttore/Membro del Consiglio | 30/09/2021 |
| OLYMPUS CORPORATION | Direttore Finanziario/CFO | 01/04/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OLYMPUS CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
SB-Kawasumi Laboratories, Inc.
 SB-Kawasumi Laboratories, Inc. Medical SpecialtiesHealth Technology Kawasumi Laboratories, Inc. engages in the manufacture and sale of medical devices and pharmaceuticals. It operates through the Hemodialysis and Plasmapheresis; and Blood Transfusion and Endovascular segments. The Hemodialysis and Plasmapheresis segment develops, produces, and sells dialyzers, blood tubing lines, arteriovenous fistula needles, and isotonic sodium chloride solutions. It also offers removal of pathogenic factors from blood by extracorporeal circulation. The Blood Transfusion and Endovascular segment offers infusion therapy products, blood bags, apheresis kits, and intravenous sets. The company was founded by Takumi Kawano on December 1, 1954 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Yasushi Sakai
